| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 14 |
| 1 | CYCLOPHOSPHAMIDE | 14 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 14 |
| 4 | OXALIPLATIN | 14 |
| 5 | DEXAMETHASONE | 11 |
| 6 | DEXAMETHASONE 1.5 MG | 11 |
| 7 | DOXORUBICIN | 11 |
| 8 | ETOPOSIDE | 11 |
| 9 | GEMCITABINE HYDROCHLORIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PINDOLOL | 2 | 0.0025 |
| 1 | CARMUSTINE | 10 | 0.0021 |
| 2 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 3 | TRIPTORELIN PAMOATE | 1 | 0.0004 |
| 4 | MELPHALAN HYDROCHLORIDE | 9 | 0.0004 |
| 5 | VINCRISTINE SULFATE | 10 | 0.0003 |
| 6 | CALCITONIN SALMON | 1 | 0.0003 |
| 7 | GOSERELIN | 4 | 0.0003 |
| 8 | ERIBULIN MESYLATE | 1 | 0.0003 |
| 9 | FLUDARABINE PHOSPHATE | 10 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 22 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 20 |
| 2 | Alkylating Drug [EPC] | 15 |
| 3 | Corticosteroid [EPC] | 15 |
| 4 | Kinase Inhibitor [EPC] | 15 |
| 5 | Topoisomerase Inhibitor [EPC] | 11 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 10 |
| 7 | Aromatase Inhibitor [EPC] | 7 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 7 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 2 | Topoisomerase Inhibitor [EPC] | 11 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 22 | 0.0001 |
| 4 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 20 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 15 | 0.0001 |
| 9 | Aromatase Inhibitor [EPC] | 7 | 0.0001 |